SCHEMBL27710372

SCHEMBL27710372

O=C(c1cccc(Cl)c1)N1CCN(c2ccc([N+](=O)[O-])c(NCc3ccco3)c2)CC1

nearest known ligand 0.82

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 14/20 0.82
ALDH1A1 P00352 9/20 0.82
NPSR1 Q6W5P4 4/20 0.81
CYP2C9 P11712 3/20 0.81
CYP2C19 P33261 3/20 0.81
CYP3A4 P08684 2/20 0.81
LMNA P02545 3/20 0.70
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
HTR6 P50406 2/20 0.66
GAA P10253 2/20 0.63
DCTPP1 Q9H773 3/20 0.59
PKM P14618 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.56
POLB P06746 1/20 0.56
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1842281 0.90 MAPT (1.00) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL2481065 0.90 MAPT (1.00) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL27690606 0.86 MAPT (1.00) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL1846393 0.86 HTR6 (0.67) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL1840598 0.86 MAPT (0.71) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL7937233 0.84 MAPT (0.78) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL7939694 0.82 MAPT (0.81) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL16299036 0.82 MAPT (0.67) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL27690607 0.82 MAPT (1.00) MAPTALDH1A1NPSR1CYP2C9CYP2C19
SCHEMBL2486196 0.81 ALDH1A1 (0.55) MAPTALDH1A1NPSR1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101133042-A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments ESTEVE LABOR DR (ES) 2008-02-27 CN claimed
CN-101563106-A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity ESTEVE LABOR DR (ES) 2009-10-21 CN disclosed
CN-101500611-A Combination of a cholinesterase inhibitor and a compound with 5-HT6 receptor affinity ESTEVE LABOR DR (ES) 2009-08-05 CN disclosed
CN-101133042-A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments ESTEVE LABOR DR (ES) 2008-02-27 CN disclosed